You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 149 No. 11, November 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Lifetime Risks of Hip, Colles', or Vertebral Fracture and Coronary Heart Disease Among White Postmenopausal Women

Steven R. Cummings, MD; Dennis M. Black, PhD; Susan M. Rubin, MPH

Arch Intern Med. 1989;149(11):2445-2448.


Abstract

• Lifetime risk is a useful way to estimate and compare the risk of various conditions. Hip fractures, Colles' fractures, and coronary heart disease, and breast and endometrial cancers are important conditions in postmenopausal women that might be influenced by the use of hormone replacement therapy. We used population-based data to estimate a woman's lifetime risk of suffering a hip, Colles', or vertebral fracture and her risk of dying of coronary heart disease. A 50-year-old white woman has a 16% risk of suffering a hip fracture, a 15% risk of suffering a Colles' fracture, and a 32% risk of suffering a vertebral fracture during her remaining lifetime. These risks exceed her risk of developing breast or endometrial cancer. She has a 31% risk of dying of coronary heart disease, which is about 10 times greater than her risk of dying of hip fractures or breast cancer. These lifetime risks provide a useful description of the comparative risks of conditions that might be influenced by postmenopausal hormone therapy.

(Arch Intern Med. 1989;149:2445-2448)



Author Affiliations

From the Division of General Internal Medicine (Dr Cummings and Ms Rubin) and the Clinical Epidemiology Program, Department of Epidemiology and Biostatistics (Drs Cummings and Black), University of California, San Francisco.


Footnotes

Accepted for publication June 23, 1989.

Reprint requests to University of California Medical Center, 400 Parnassus, A-405, San Francisco, CA 94143-0320 (Dr Cummings).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Osteoporosis Disease Management: What Every Orthopaedic Surgeon Should Know
Dell et al.
JBJS 2009;91:79-86.
FULL TEXT  

Age Differences in Energy Absorption in the Upper Extremity During a Descent Movement: Implications for Arresting a Fall
Sran et al.
J Gerontol A Biol Sci Med Sci 2009;0:glp153v1-glp153.
ABSTRACT | FULL TEXT  

Trends in the United States in the Treatment of Distal Radial Fractures in the Elderly
Chung et al.
JBJS 2009;91:1868-1873.
ABSTRACT | FULL TEXT  

Teriparatide and Raloxifene Reduce the Risk of New Adjacent Vertebral Fractures in Postmenopausal Women with Osteoporosis. Results from Two Randomized Controlled Trials
Bouxsein et al.
JBJS 2009;91:1329-1338.
ABSTRACT | FULL TEXT  

Osteoporosis Disease Management: The Role of the Orthopaedic Surgeon
Dell et al.
JBJS 2008;90:188-194.
FULL TEXT  

Loss of trabeculae by mechano-biological means may explain rapid bone loss in osteoporosis
Mulvihill et al.
J R Soc Interface 2008;5:1243-1253.
ABSTRACT | FULL TEXT  

A sheep model for fracture treatment in osteoporosis: benefits of the model versus animal welfare
Egermann et al.
Lab Anim 2008;42:453-464.
ABSTRACT | FULL TEXT  

Low Incidence of Anti-Osteoporosis Treatment After Hip Fracture
Rabenda et al.
JBJS 2008;90:2142-2148.
ABSTRACT | FULL TEXT  

Postfracture care for older women: Gaps between optimal care and actual care
Metge et al.
cfp 2008;54:1270-1276.
ABSTRACT | FULL TEXT  

Mechanism of Action, Pharmacokinetic and Pharmacodynamic Profile, and Clinical Applications of Nitrogen-containing Bisphosphonates
Kimmel
JDR 2007;86:1022-1033.
ABSTRACT | FULL TEXT  

Heart Disease and Stroke Statistics--2007 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Rosamond et al.
Circulation 2007;115:e69-e171.
FULL TEXT  

Analysis of the absolute risks in coeliac disease indicates the importance of the prevention of osteoporosis * Author's reply
Walters and West
Gut 2007;56:310-311.
FULL TEXT  

Screening in women's health, with emphasis on fetal Down's syndrome, breast cancer and osteoporosis
Wildschut et al.
Hum Reprod Update 2006;12:499-512.
ABSTRACT | FULL TEXT  

The Lifetime Risk of Stroke: Estimates From the Framingham Study
Seshadri et al.
Stroke 2006;37:345-350.
ABSTRACT | FULL TEXT  

Fracture Prevention With Vitamin D Supplementation: A Meta-analysis of Randomized Controlled Trials
Bischoff-Ferrari et al.
JAMA 2005;293:2257-2264.
ABSTRACT | FULL TEXT  

Postmenopausal hormone therapy: from monkey glands to transdermal patches
Davis et al.
J Endocrinol 2005;185:207-222.
ABSTRACT | FULL TEXT  

Utility of testing for monoclonal bands in serum of patients with suspected osteoporosis: retrospective, cross sectional study
Abrahamsen et al.
BMJ 2005;330:818.
ABSTRACT | FULL TEXT  

Women's Perceptions of Future Risk After Low-Energy Fractures at Midlife
Meadows et al.
Ann Fam Med 2005;3:64-69.
ABSTRACT | FULL TEXT  

Diagnosis of Osteoporotic Vertebral Fractures: Importance of Recognition and Description by Radiologists
Lenchik et al.
Am. J. Roentgenol. 2004;183:949-958.
FULL TEXT  

Lifetime Risk for Development of Atrial Fibrillation: The Framingham Heart Study
Lloyd-Jones et al.
Circulation 2004;110:1042-1046.
ABSTRACT | FULL TEXT  

Osteoporosis: An Under-appreciated Complication of Diabetes
Brown and Sharpless
Clin. Diabetes 2004;22:10-20.
ABSTRACT | FULL TEXT  

Aging Bone and Osteoporosis: Strategies for Preventing Fractures in the Elderly
Ettinger
Arch Intern Med 2003;163:2237-2246.
ABSTRACT | FULL TEXT  

Lifetime Risk for Diabetes Mellitus in the United States
Narayan et al.
JAMA 2003;290:1884-1890.
ABSTRACT | FULL TEXT  

Detecting the risks of osteoporotic fractures in coeliac disease
Walters and van Heel
Gut 2003;52:1229-1230.
FULL TEXT  

Lignes directrices de pratique clinique 2002 pour le diagnostic et le traitement de l'osteoporose au Canada
Brown and Josse
CMAJ 2003;168:SF1-38.
ABSTRACT | FULL TEXT  

Poor response to ovulation induction is a stronger predictor of early menopause than elevated basal FSH: a life table analysis
Lawson et al.
Hum Reprod 2003;18:527-533.
ABSTRACT | FULL TEXT  

Lifetime Risk for Developing Congestive Heart Failure: The Framingham Heart Study
Lloyd-Jones et al.
Circulation 2002;106:3068-3072.
ABSTRACT | FULL TEXT  

2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada
Brown and Josse
CMAJ 2002;167:s1-34.
ABSTRACT | FULL TEXT  

Hip protector compliance among older people living in residential care homes
Cryer et al.
Inj. Prev. 2002;8:202-206.
ABSTRACT | FULL TEXT  

Meta-Analyses of Therapies for Postmenopausal Osteoporosis * I. Systematic Reviews of Randomized Trials in Osteoporosis: Introduction and Methodology
Cranney et al.
Endocr. Rev. 2002;23:496-507.
ABSTRACT | FULL TEXT  

Effect of Birth Cohort on Risk of Hip Fracture: Age-Specific Incidence Rates in the Framingham Study
Samelson et al.
AJPH 2002;92:858-862.
ABSTRACT | FULL TEXT  

Residual Lifetime Risk for Developing Hypertension in Middle-aged Women and Men: The Framingham Heart Study
Vasan et al.
JAMA 2002;287:1003-1010.
ABSTRACT | FULL TEXT  

Antiresorptive Treatment of Postmenopausal Osteoporosis: Comparison of Study Designs and Outcomes in Large Clinical Trials with Fracture as an Endpoint
Marcus et al.
Endocr. Rev. 2002;23:16-37.
ABSTRACT | FULL TEXT  

Mice with a Targeted Deletion of the Tetranectin Gene Exhibit a Spinal Deformity
Iba et al.
Mol. Cell. Biol. 2001;21:7817-7825.
ABSTRACT | FULL TEXT  

A Comparison of the Effects of Raloxifene and Estrogen on Bone in Postmenopausal Women
Prestwood et al.
J. Clin. Endocrinol. Metab. 2000;85:2197-2202.
ABSTRACT | FULL TEXT  

When is an HIV Infection Prevented and when is it Merely Delayed?
Pinkerton et al.
Eval Rev 2000;24:251-271.
ABSTRACT  

Diet, smoking and anthropometric indices and postmenopausal bone fractures: a prospective study
Kato et al.
Int J Epidemiol 2000;29:85-92.
ABSTRACT | FULL TEXT  

Individualizing Therapy to Prevent Long-term Consequences of Estrogen Deficiency in Postmenopausal Women
Col et al.
Arch Intern Med 1999;159:1458-1466.
ABSTRACT | FULL TEXT  

Current Concepts Review - Bone Densitometry in Orthopaedic Practice
MIRSKY and EINHORN
JBJS 1998;80:1687-98.
FULL TEXT  

Calcium Intake and the Incidence of Forearm and Hip Fractures among Men
Owusu et al.
J. Nutr. 1997;127:1782-1787.
ABSTRACT | FULL TEXT  

Postmenopausal Hormone-Replacement Therapy -- Time for a Reappraisal?
Brinton and Schairer
NEJM 1997;336:1821-1822.
FULL TEXT  

Prevention of Nonvertebral Fractures by Alendronate: A Meta-analysis
Karpf et al.
JAMA 1997;277:1159-1164.
ABSTRACT  

Racial Differences in Bone Density between Young Adult Black and White Subjects Persist after Adjustment for Anthropometric, Lifestyle, and Biochemical Differences
Ettinger et al.
J. Clin. Endocrinol. Metab. 1997;82:429-434.
ABSTRACT | FULL TEXT  

Osteoporosis: Frequency, Consequences, and Risk Factors
Ross
Arch Intern Med 1996;156:1399-1411.
ABSTRACT  

Risk Factors for Hip Fracture in White Women
Cummings et al.
NEJM 1995;332:767-774.
ABSTRACT | FULL TEXT  

Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women
Grady et al.
ANN INTERN MED 1992;117:1016-1037.
ABSTRACT  

Bone Gain in Young Adult Women
Recker et al.
JAMA 1992;268:2403-2408.
ABSTRACT  

A Model of Lifetime Osteoporosis Impact
Chrischilles et al.
Arch Intern Med 1991;151:2026-2032.
ABSTRACT  

Should Prescription of Postmenopausal Hormone Therapy Be Based on the Results of Bone Densitometry?
Cummings et al.
ANN INTERN MED 1990;113:565-567.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.